Atlas FDA

SUPARTZ

FDA premarket approval P980044/S005 · decided 2007-02-13

Approval details

PMA number
P980044
Supplement
S005
Supplement type
135 Review Track For 30-Day Notice
Supplement reason
Process Change - Manufacturer/Sterilizer/Packager/Supplier
Trade name
SUPARTZ
Generic name
Acid, hyaluronic, intraarticular
Applicant
Seikagaku Corp.
Date received
2006-08-01
Decision date
2007-02-13
Days to decision
196 days
Decision code
APPR
Product code
MOZ
Advisory committee
Orthopedic
Expedited review
No
Location
Tokyo
Statement
APPROVAL FOR THE ELIMINATION OF A STEP IN THE ACTIVE INGREDIENT SODIUM HYALURONATE MANUFACTURING PROCESS AND MOVING THAT MANUFACTURING PROCESS FROM THE CURRENT TWO BUILDINGS TO A NEW WING IN AN EXISTING BUILDING.

Class III intelligence, same tools

PMAs share the API, exports and alerts with 510(k) data - watch an applicant and hear about every approval.

510(k) clearances by this applicant

RecordFirmDate
HADGEL, 4 GRAM/SYRINGE (K011544)Seikagaku Corp.2001-08-15